Ganga Pharmaceuticals Limited (BOM:539680)

Ganga Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 4, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	74	71	49	118	57	42
Market Cap Growth	-14.38%	44.22%	-58.34%	108.67%	35.90%	36.67%
Enterprise Value	84	86	60	135	75	59
Last Close Price	12.50	12.00	10.17	24.41	13.93	10.25

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 4, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	73.53	69.89	62.26	253.25	143.94	109.87
PS Ratio	2.61	2.51	1.87	4.32	2.19	1.67
PB Ratio	0.89	0.85	0.69	1.67	1.04	0.77
P/TBV Ratio	0.89	0.85	0.69	1.67	1.04	0.77

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 4, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
EV/Sales Ratio	2.98	3.05	2.28	4.94	2.91	2.36
EV/EBITDA Ratio	215.38	220.58	-	234.37	1591.29	139.49
EV/EBIT Ratio	-	-	-	1606.20	-	-

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 4, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Debt / Equity Ratio	0.13	0.13	0.20	0.19	0.34	0.36
Debt / EBITDA Ratio	27.88	27.88	-	23.54	386.63	45.76
Net Debt / Equity Ratio	0.12	0.12	0.16	0.19	0.33	0.35
Net Debt / EBITDA Ratio	26.39	26.39	-9.62	23.03	380.49	45.28
Net Debt / FCF Ratio	-0.77	-0.77	-1.65	-1.03	-32.89	-8.46
Asset Turnover	0.30	0.30	0.30	0.33	0.32	0.32
Inventory Turnover	1.12	1.12	1.01	1.03	1.07	1.13
Quick Ratio	0.81	0.81	0.76	0.80	0.49	0.54
Current Ratio	6.12	6.12	4.28	4.81	2.72	2.91
Return on Equity (ROE)	1.31%	1.31%	1.11%	0.75%	0.72%	0.70%
Return on Assets (ROA)	-0.11%	-0.11%	-1.16%	0.06%	-0.40%	-0.10%
Return on Invested Capital (ROIC)	-0.14%	-0.15%	-1.63%	0.08%	-0.52%	-0.13%
Return on Capital Employed (ROCE)	-0.20%	-0.20%	-2.20%	0.10%	-0.80%	-0.20%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 4, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Earnings Yield	1.37%	1.43%	1.61%	0.40%	0.69%	0.91%
FCF Yield	-18.24%	-19.00%	-13.74%	-10.90%	-0.97%	-5.42%
Buyback Yield / Dilution	10.59%	10.59%	-	-62.79%	-	-

Data Source: S&P Global Market Intelligence Last updated: Sep 1, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 28, 2026

Data Sources Report a data error